Quetiapine Impurity 12 | CAS 2206135-50-2 - Request Quote
Quetiapine Impurity 12
| SZ CAT No: | SZ-Q001054 |
| CAS No | 2206135-50-2 |
| Mol.F. | C25H18N2S2 |
| Mol.Wt. | 410.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Quetiapine Impurity 12 is chemically N-(2-(phenylthio)phenyl)dibenzo[b,f][1,4]thiazepin-11-amine. Quetiapine Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Quetiapine Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Quetiapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2206135-50-2
Purchase 2206135-50-2
Order 2206135-50-2
Enquire 2206135-50-2
price of 2206135-50-2
2206135-50-2 Supplier
2206135-50-2 Manufacturer
2206135-50-2 Exporter
buy high quality Quetiapine Impurity 12
Purchase Quetiapine Impurity 12
Quetiapine Impurity 12 suppliers
Quetiapine Impurity 12 manufacturers
Quetiapine Impurity 12 price
Order Quetiapine Impurity 12
Enquire Quetiapine Impurity 12
Quetiapine Impurity 12 cost
Quetiapine Impurity 12 Supplier
Quetiapine Impurity 12 Distributor
Quetiapine Impurity 12 for Method Validation
Quetiapine Reference Standard
Quetiapine Impurity 12 for ANDA Filing
Quetiapine Impurity 12 for Forced Degradation Studies
Quetiapine Impurity 12 Identification Standards
Quetiapine Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.